Abstract
COVID-19 literally ambushed humanity and took the medical world by surprise with no adequate arrangement to manage it in terms of appropriate drugs and vaccine as the origin of the disease still remains a mystery. There has been aggressive search for an appropriate drug that will bring this pandemic with high mortality under control. This study took time to carry out a literature search on the drugs and medications so far tried on COVID-19 patients since its outbreak in Wuhan China to date. We carried out search on Medline, PubMed, SciElo, Google scholar, among others on drugs used for SARS-COV-2 infections and some of the documented outcomes. The study found a constraint in time by researchers to carry out a comprehensive study on any of the drugs since the disease was causing high mortalities across the globe. Most of the drugs that appeared beneficial and non-beneficial in treatment of SARS-COV-2 infections did not use adequate samples enough to draw statistically significant inferences. At the moment, high-impact treatment options for COVID-19 are; Antiviral drugs, Anti-inflammatory drugs, ACE inhibitors and angiotensin receptor blockers, Hydroxychloroquine + Azithromycin and convalescent serum among several other options including COVID organics. We however recommend that treating Physicians are at liberty to use appropriate combination of medications at their disposal based on information provided below as we lack sufficient proof to make any drug recommendation. This may possibly reduce the rates of disease progressions from mild into severe disease requiring intensive care and ventilators.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Western Journal of Medical and Biomedical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.